The results revealed that GALE expression in the atopic dermatitis model group showed only a modest increase compared to controls (fold change = 1.16, representing a 16% increase), suggesting that GALE dysregulation may not be a primary driver in AD pathogenesis. The gene discussed is GALE; the disease is atopic eczema.